InspireMD (NSPR) Tops Q3 EPS by 2c

InspireMD (NYSE: NSPR) reported Q3 EPS of ($0.48), $0.02 better than the analyst estimate of ($0.50). Revenue for the quarter came in at $632 thousand versus the consensus estimate of $900 thousand.

For earnings history and earnings-related data on InspireMD (NSPR) click here.

You May Also Be Interested In

• Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
• William Blair Starts Yesway Inc (YSWY) at Outperform
• Goldman Sachs Upgrades XD Inc (2400:HK) (XDNCF) to Buy